Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference

Author's Avatar
May 09, 2022

Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced a poster presentation at TIDES USA 2022, May 9-12, 2022.